Stock Events

Stock Events

DarioHealth 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q1 2026
Q2 2026
Next
-1.26
-1.09
-0.91
-0.74
Expected EPS
-0.8177599999999999
Actual EPS
N/A

Financials

-274.34%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
19.52MRevenue
-53.55MNet Income

Analyst Ratings

7.59Average Price Target
The highest estimate is 9.11.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LS1P.STU. It's not an investment recommendation.
NVIDIA
5
NVDA
Palantir Technologies
5
PLTR
AMD
4
AMD
Walt Disney Co)
4
DIS

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teladoc Health
TDOC
Mkt Cap1.18B
Teladoc provides telehealth services, competing directly with DarioHealth's digital health platforms for remote patient monitoring and engagement.
Dexcom
DXCM
Mkt Cap34.27B
Dexcom offers continuous glucose monitoring systems, directly competing with DarioHealth's diabetes and blood glucose monitoring solutions.
Tandem Diabetes Care
TNDM
Mkt Cap1.49B
Tandem Diabetes Care manufactures and sells insulin pumps and other diabetes management devices, competing in the diabetes care space with DarioHealth.
Insulet
PODD
Mkt Cap10.07B
Insulet Corporation produces the Omnipod, an insulin management system, which competes with DarioHealth's diabetes management solutions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers a wide range of medical devices including diabetes management products, competing with DarioHealth's digital health solutions for diabetes.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories provides a broad portfolio of health care products, including the FreeStyle Libre, a glucose monitoring system competing with DarioHealth's offerings.
Omnicell
OMCL
Mkt Cap1.51B
Omnicell provides automation and business analytics software for healthcare organizations, indirectly competing with DarioHealth's digital health management solutions.
Koninklijke Philips N.V.
PHG
Mkt Cap26.12B
Philips offers a wide range of health technology products and services, including remote patient monitoring, competing with DarioHealth's digital health platforms.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew specializes in medical equipment for surgery, wound management, and more, indirectly competing with DarioHealth by offering alternative healthcare solutions.

About

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
Show more...
CEO
Erez Raphael
Employees
165
Country
United States
ISIN
US23725P2092

Listings

MU
DE
LS1P.MU
STU
DE
LS1N.STU
STU
DE
LS1P.STU
XNAS
US
DRIO

0 Comments

Share your thoughts

FAQ

What is DarioHealth stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange DarioHealth stocks are traded under the ticker LS1P.STU.
When is the next DarioHealth earnings date?▼
DarioHealth is going to release the next earnings report on November 16, 2026.
What were DarioHealth earnings last quarter?▼
LS1P.STU earnings for the last quarter are -0.74 EUR per share, whereas the estimation was -1.05 EUR resulting in a +30.04% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is DarioHealth revenue for the last year?▼
DarioHealth revenue for the last year amounts to 19.52M EUR.
What is DarioHealth net income for the last year?▼
LS1P.STU net income for the last year is -53.55M EUR.
How many employees does DarioHealth have?▼
As of September 06, 2026, the company has 165 employees.
In which sector is DarioHealth located?▼
DarioHealth operates in the Health & Wellness sector.
When did DarioHealth complete a stock split?▼
The last stock split for DarioHealth was on August 28, 2025 with a ratio of 1:20.
Where is DarioHealth headquartered?▼
DarioHealth is headquartered in NEW YORK, United States.